Publication: Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon
Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon
Date
Date
Date
Citations
Donington, J. S., Gitlitz, B., Lim, E., Opitz, I., Kim, Y. T., & Altorki, N. (2023). Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. Annals of Thoracic Surgery, 115(6), 1544–1555. https://doi.org/10.1016/j.athoracsur.2022.09.029
Abstract
Abstract
Abstract
BACKGROUND
This review describes a new therapeutic landscape in the adjuvant treatment of resectable non-small cell lung cancer (NSCLC) and discusses the role of the surgeon in ensuring the best outcomes within this treatment paradigm.
METHODS
We conducted a narrative literature review using the search terms "non-small cell lung cancer" and "adjuvant" to identify randomized Phase III trials of systemic adjuvant therapy for NSCLC through March 17, 2022. We also searched ClinicalTrials.gov to identify ongoing trials of adjuvant immun
Metrics
Views
Additional indexing
Creators (Authors)
Volume
Volume
Volume
Number
Number
Number
Page range/Item number
Page range/Item number
Page range/Item number
Page end
Page end
Page end
Item Type
Item Type
Item Type
In collections
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Publication date
Publication date
Publication date
Date available
Date available
Date available
ISSN or e-ISSN
ISSN or e-ISSN
ISSN or e-ISSN
OA Status
OA Status
OA Status
Free Access at
Free Access at
Free Access at
Publisher DOI
Metrics
Views
Citations
Donington, J. S., Gitlitz, B., Lim, E., Opitz, I., Kim, Y. T., & Altorki, N. (2023). Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. Annals of Thoracic Surgery, 115(6), 1544–1555. https://doi.org/10.1016/j.athoracsur.2022.09.029